NSP7 Molecular Degrader Attenuates Coronaviral Infection Through the β‐TrCP1/FBXO5 Axis
Abstract NSP7 (Non‐Structural Protein 7) of SARS‐CoV‐2 is a crucial component for viral replication and transcription. In this study, it is revealed that the host E3 ubiquitin ligase FBXO5 suppresses viral replication by mediating NSP7 lysine‐48‐linked ubiquitination and subsequent proteasomal degra...
| Published in: | Advanced Science |
|---|---|
| Main Authors: | Yao Tong, Travis B. Lear, Ferhan Tuncer, John J. Villandre, Áine N. Boudreau, Bo Lin, Irene Alfaras, Jason R. Kennerdell, Daniel P. Camarco, Mads B. Larsen, Yun Hua, Yanwen Chen, Meigin E. Chandler, Ricardo Pineda, Simon M. Barratt‐Boyes, John W. Evankovich, Toren Finkel, Yuan Liu, Bill B. Chen |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202500798 |
Similar Items
Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH
by: Raquel Fernández-Ginés, et al.
Published: (2024-02-01)
by: Raquel Fernández-Ginés, et al.
Published: (2024-02-01)
SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
by: Yanpeng Ci, et al.
Published: (2018-03-01)
by: Yanpeng Ci, et al.
Published: (2018-03-01)
Exploring the role of FBXO5 in gastric cancer
by: Junchang Zhang, et al.
Published: (2023-06-01)
by: Junchang Zhang, et al.
Published: (2023-06-01)
SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
by: Ying Ma, et al.
Published: (2019-02-01)
by: Ying Ma, et al.
Published: (2019-02-01)
Role of arbutin in the inhibition of FBXO5 in hepatocellular carcinoma
by: Shuo Zhang, et al.
Published: (2024-12-01)
by: Shuo Zhang, et al.
Published: (2024-12-01)
Inter-Fighting between Influenza A Virus NS1 and β-TrCP: A Novel Mechanism of Anti-Influenza Virus
by: Haiwei Sun, et al.
Published: (2022-10-01)
by: Haiwei Sun, et al.
Published: (2022-10-01)
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells
by: Tomeka L. Suber, et al.
Published: (2018-10-01)
by: Tomeka L. Suber, et al.
Published: (2018-10-01)
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21
by: Long Zhang, et al.
Published: (2019-02-01)
by: Long Zhang, et al.
Published: (2019-02-01)
Long Non-Coding RNA B3GALT5-AS1 Suppresses Keloid Progression by Regulating the β-Trcp1-Mediated Ubiquitination of HuR
by: Ye W, et al.
Published: (2024-04-01)
by: Ye W, et al.
Published: (2024-04-01)
Clinical significance of FBXO17 gene expression in high-grade glioma
by: Di Du, et al.
Published: (2018-07-01)
by: Di Du, et al.
Published: (2018-07-01)
SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer
by: Liangshan Li, et al.
Published: (2025-08-01)
by: Liangshan Li, et al.
Published: (2025-08-01)
Fbxo45 facilitates the malignant progression of breast cancer by targeting Bim for ubiquitination and degradation
by: Mengmeng Zheng, et al.
Published: (2024-05-01)
by: Mengmeng Zheng, et al.
Published: (2024-05-01)
An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver
by: Raquel Fernández-Ginés, et al.
Published: (2022-09-01)
by: Raquel Fernández-Ginés, et al.
Published: (2022-09-01)
A novel β-TrCP1/NRF2 interaction inhibitor for effective anti-inflammatory therapy
by: Ángel J. García-Yagüe, et al.
Published: (2025-07-01)
by: Ángel J. García-Yagüe, et al.
Published: (2025-07-01)
FBXO45 levels regulated ferroptosis renal tubular epithelial cells in a model of diabetic nephropathy by PLK1
by: Zhu Bingming, et al.
Published: (2024-05-01)
by: Zhu Bingming, et al.
Published: (2024-05-01)
Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma
by: Jianwu Zhou, et al.
Published: (2024-08-01)
by: Jianwu Zhou, et al.
Published: (2024-08-01)
Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma
by: Bo Fan, et al.
Published: (2019-06-01)
by: Bo Fan, et al.
Published: (2019-06-01)
FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
by: Guan Jian, et al.
Published: (2025-08-01)
by: Guan Jian, et al.
Published: (2025-08-01)
PIM1 Attenuates Innate Immunity to Foster Coronavirus Replication through Ubiquitin Ligase β‐TrCP‐Mediated IFNAR1 Degradation
by: Qianya Wan, et al.
Published: (2025-10-01)
by: Qianya Wan, et al.
Published: (2025-10-01)
The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc
by: Qiong Wei, et al.
Published: (2024-08-01)
by: Qiong Wei, et al.
Published: (2024-08-01)
FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation
by: Sirui Hang, et al.
Published: (2025-09-01)
by: Sirui Hang, et al.
Published: (2025-09-01)
β-TrCP Restricts Lipopolysaccharide (LPS)-Induced Activation of TRAF6-IKK Pathway Upstream of IκBα Signaling
by: Jin Liu, et al.
Published: (2018-12-01)
by: Jin Liu, et al.
Published: (2018-12-01)
FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing
by: Shangbiao Li, et al.
Published: (2023-11-01)
by: Shangbiao Li, et al.
Published: (2023-11-01)
FBXO10 Drives Hepatocellular Carcinoma Proliferation via K63-Linked Ubiquitination and Stabilization of FRMPD1
by: Wuguang Liu, et al.
Published: (2025-05-01)
by: Wuguang Liu, et al.
Published: (2025-05-01)
Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4
by: Arushi Vats, et al.
Published: (2025-02-01)
by: Arushi Vats, et al.
Published: (2025-02-01)
AMPK-Mediated Phosphorylation of Nrf2 at S374/S408/S433 Favors Its βTrCP2-Mediated Degradation in KEAP1-Deficient Cells
by: Eleni Petsouki, et al.
Published: (2023-08-01)
by: Eleni Petsouki, et al.
Published: (2023-08-01)
FBXO6 as a potential prognostic biomarker linked to immune infiltration in ccRCC based on integrated RNA and single-cell sequencing analysis
by: Zekun Xin, et al.
Published: (2025-09-01)
by: Zekun Xin, et al.
Published: (2025-09-01)
FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
by: Chun-Ming Li, et al.
Published: (2023-03-01)
by: Chun-Ming Li, et al.
Published: (2023-03-01)
Interactions between the otitis media gene, Fbxo11, and p53 in the mouse embryonic lung
by: Hilda Tateossian, et al.
Published: (2015-12-01)
by: Hilda Tateossian, et al.
Published: (2015-12-01)
Ubiquitination and ALL: Identifying FBXO8 as a prognostic biomarker and therapeutic target
by: Wei Xian, et al.
Published: (2025-05-01)
by: Wei Xian, et al.
Published: (2025-05-01)
Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells
by: Suzanne Pickering, et al.
Published: (2023-08-01)
by: Suzanne Pickering, et al.
Published: (2023-08-01)
FBXO45 restricts HIV-1 replication by inducing SQSTM1/p62-mediated autophagic degradation of Tat
by: Mingxiu Xu, et al.
Published: (2025-03-01)
by: Mingxiu Xu, et al.
Published: (2025-03-01)
Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion
by: Rulan Ma, et al.
Published: (2023-05-01)
by: Rulan Ma, et al.
Published: (2023-05-01)
LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling
by: Yiming Zhang, et al.
Published: (2023-06-01)
by: Yiming Zhang, et al.
Published: (2023-06-01)
Retracted: The F‐box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin‐mediated degradation of Snail
by: Lijiang Shao, et al.
Published: (2020-09-01)
by: Lijiang Shao, et al.
Published: (2020-09-01)
FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway
by: Wenke Guo, et al.
Published: (2024-09-01)
by: Wenke Guo, et al.
Published: (2024-09-01)
FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis
by: Xi Chen, et al.
Published: (2016-11-01)
by: Xi Chen, et al.
Published: (2016-11-01)
SIRT1 Stabilizes β-TrCP1 to Inhibit Snail1 Expression in Maintaining Intestinal Epithelial Integrity to Alleviate ColitisSummary
by: Liang Wang, et al.
Published: (2024-01-01)
by: Liang Wang, et al.
Published: (2024-01-01)
A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma
by: Dute Gao, et al.
Published: (2024-05-01)
by: Dute Gao, et al.
Published: (2024-05-01)
FBXO24 modulates mRNA alternative splicing and MIWI degradation and is required for normal sperm formation and male fertility
by: Zhiming Li, et al.
Published: (2024-03-01)
by: Zhiming Li, et al.
Published: (2024-03-01)
Similar Items
-
Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH
by: Raquel Fernández-Ginés, et al.
Published: (2024-02-01) -
SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
by: Yanpeng Ci, et al.
Published: (2018-03-01) -
Exploring the role of FBXO5 in gastric cancer
by: Junchang Zhang, et al.
Published: (2023-06-01) -
SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
by: Ying Ma, et al.
Published: (2019-02-01) -
Role of arbutin in the inhibition of FBXO5 in hepatocellular carcinoma
by: Shuo Zhang, et al.
Published: (2024-12-01)
